Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

63.52
+1.482.38%
Volume:1.64M
Turnover:104.36M
Market Cap:10.56B
PE:-18.25
High:64.18
Open:62.19
Low:62.19
Close:62.04
52wk High:86.74
52wk Low:41.71
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.64
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:24.00
PE(LYR):-26.67

Loading ...

May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 02, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 27, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 17, 2020

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Jan 16, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Dec 23, 2019

Major Issues Report

Current report, items 1.01, 2.03, 3.02, and 9.01
Dec 20, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 13, 2019

Major Issues Report

Current report, items 2.03, 3.02, and 8.01
Dec 12, 2019

Major Issues Report

Current report, items 2.03, 3.02, 8.01, and 9.01
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 30, 2019

Major Issues Report

Current report, item 1.02